PolyPid joins US infectious disease program

I reported previously (twice) about Israel’s PolyPid slow-release antibiotic bone implants.  PolyPid has just been accepted into the US FDA Qualified Infectious Disease Program – a new FDA status for innovative products in the treatment of bacteria resistant to antibiotics.

http://www.globes.co.il/en/article-fda-fast-tracks-israeli-co-polypid-1001180587

This entry was posted in Israel's Medical Achievements. Bookmark the permalink.

Leave a Reply

Your email address will not be published. Required fields are marked *